Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
Kymera Therapeutics (KYMR) Ownership - Who Owns Kymera Therapeutics?
181 Followers
Kymera Therapeutics (KYMR) Ownership Overview
38.02% Insiders
33.02% Mutual Funds
13.93% Other Institutional Investors
15.03% Public Companies and
Individual Investors
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail and individual investors. Approximately 46.95% of the company’s stock is owned by Institutional Investors, 38.02% is owned by Insiders and 15.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 23, 2024 | xxxxxxxxxxxxx | $90099 | |
| Mar 04, 2024 | Jared Gollob Cmo | xxxxxxxxxxxxx | $139956 |
| Mar 04, 2024 | xxxxxxxxxxxxx | $164651 | |
| Jan 05, 2024 | xxxxxxxxxxxxx | $74401 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $284455 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $303791 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $5346157 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $20137386 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,995,928 | Institution | 9.77% | 290,742,549 | |
| 4,516,718 | Institution | 7.36% | 219,015,656 | |
| 4,183,988 | Institution | 6.82% | 202,881,578 | |
| 2,986,850 | Institution | 4.87% | 144,832,357 | |
| 2,134,444 | Institution | 3.48% | 103,499,190 | |
| 1,598,841 | Institution | 2.61% | 77,527,800 | |
| 1,446,764 | Institution | 2.36% | 70,153,586 | |
| 1,276,841 | Institution | 2.08% | 61,914,020 | |
| 1,075,438 | Institution | 1.75% | 52,147,989 | |
| 984,991 | Institution | 1.61% | 47,762,214 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,183,988 | Institution | 6.82% | 202,881,578 | |
| 2,986,850 | Institution | 4.87% | 144,832,357 | |
| 1,598,841 | Institution | 2.61% | 77,527,800 | |
| 1,446,764 | Institution | 2.36% | 70,153,586 | |
| 1,276,841 | Institution | 2.08% | 61,914,020 | |
| 1,075,438 | Institution | 1.75% | 52,147,989 | |
| 612,508 | Institution | 1.00% | 29,700,513 | |
| 596,094 | Institution | 0.97% | 28,904,598 | |
| 555,761 | Institution | 0.91% | 26,948,851 | |
| 508,826 | Institution | 0.83% | 24,672,973 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,130,663 | Institution | 1.84% | 50,879,835 | |
| 1,528,965 | Institution | 2.49% | 49,095,066 | |
| 1,246,304 | Institution | 2.03% | 40,018,821 | |
| 928,093 | Institution | 1.51% | 39,258,334 | |
| 709,588 | Institution | 1.16% | 22,784,871 | |
| 651,011 | Institution | 1.06% | 20,903,963 | |
| 396,167 | Institution | 0.65% | 17,827,515 | |
| 395,378 | Institution | 0.64% | 17,792,010 | |
| 208,854 | Institution | 0.34% | 8,834,524 | |
| 154,459 | Institution | 0.25% | 4,959,678 |
FAQ
Who Owns Kymera Therapeutics (KYMR)?
According to the latest TipRanks data, approximately 13.93% of the company's stock is held by institutional investors, 38.02% is held by insiders, and 15.03% is held by retail investors.
What percentage of Kymera Therapeutics (KYMR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.93% of Kymera Therapeutics (KYMR) stock is held by institutional investors.
What percentage of Kymera Therapeutics (KYMR) stock is held by retail investors?
According to the latest TipRanks data, approximately 15.03% of Kymera Therapeutics (KYMR) stock is held by retail investors.
Who owns the most shares of Kymera Therapeutics (KYMR)?
Felix Baker owns the most shares of Kymera Therapeutics (KYMR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.